Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports.Check Now!

Hyperopia - Epidemiology Forecast-2034

Published Date : 2025
Pages : 80
Region : United States, Japan, EU4 & UK
SALE

Share:

hyperopia epidemiology forecast insight

DelveInsight’s ‘Hyperopia (farsightedness)- Epidemiology Forecast to 2034’ report delivers an in-depth understanding of the disease, historical and forecasted Hyperopia epidemiology in the 7MM, i.e., the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Geographies Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2021-2034

Hyperopia Understanding

Refractive error indicates that the eye shape does not correctly bend light, resulting in a blurred image. Myopia (nearsightedness), hyperopia (farsightedness), presbyopia (near vision loss with age), and astigmatism are the major forms of refractive errors. Hyperopia, also known as farsightedness, is a refractive defect in which distant objects are usually seen more clearly, but closer objects appear to be blurred.When the eyeball is shorter than normal or has a cornea (clear front window of the eye) that is too flat, hyperopia appears. As a consequence, instead of on it, light rays focus behind the retina. Conventionally, hyperopia is classified into low, moderate, and high to denote the degree of the condition. An error of +2.00 diopters (D) or less is considered low hyperopia. The error between +2.25 and +5.00 D is considered moderate hyperopia, and above this range, it is regarded as high hyperopia. The signs and symptoms of this condition incorporate difficulty with close tasks like reading, eye strain, blurry vision, squinting, and headaches. Symptoms are more prone to manifest with higher degrees of hyperopia. Nonetheless, few patients may encounter all these symptoms, while others may experience some or none, even with a high degree of hyperopia. Hyperopia is believed to be a hereditary condition that runs in families. Other than genetics, age and underlying medical conditions, such as diabetes, can also contribute to hyperopia development. For the diagnosis purpose, a basic eye test involving a refraction examination and an eye health exam is generally used to detect hyperopia. The doctor looks for clinical signs like visual acuity and performs tests such as corneal examination, pupil examination, slit-lamp examination, retinal examination, and eyelid and conjunctival examination. However, if the diagnosis is delayed or the condition is left untreated in children, complications can arise and may even permanently impair their vision.

Epidemiology Perspective by DelveInsight

The Hyperopia epidemiology division provides the insights about historical and current Hyperopia patient pool and forecasted trend for each seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

 

Key Findings

In 2020, the overall prevalent cases of Hyperopia accessed to be around 87,668,351 in the 7MM, which are expected to grow during the forecast period, i.e., 2025-2034.

 

The disease epidemiology covered in the report provides historical as well as forecasted Hyperopia epidemiology [segmented as Total Prevalent cases of Hyperopia, Total Diagnosed Prevalent cases of Hyperopia, Gender-specific Diagnosed Prevalent Cases of Hyperopia, Age-specific Diagnosed Prevalent Cases of Hyperopia, Severity-Specific Diagnosed Prevalent Cases of Hyperopia and Treated cases of Hyperopia] in the 7MM, covering the United States, EU5 countries (Germany, France, Italy, Spain, and United Kingdom), and Japan from 2021 to 2034.

Country Wise- Hyperopia Epidemiology

  • In the United States, the total number of prevalent cases of Hyperopia were 16,030,244 in the year 2020 which are expected to grow during the study period, i.e., 2021-2034.
  • In the year 2020, the total prevalent cases of Hyperopia were 49,755,755 in EU-5, which are expected to grow during the study period, i.e., 2021-2034.
  • In Japan, the total number of prevalent cases of Hyperopia was 21,882,353 in the year 2020 which are expected to grow during the study period, i.e., 2021-2034.
  • In 2020, mild and moderate-to-severe cases of Hyperopia were accounted for 1,522,873 and 13,705,858 in the United States.
  • In the 7MM, the age-specific diagnosed prevalent cases of Hyperopia were 7,713,123, 15,203,292, 18,222,168, 14,995,944, and 12,708,668 for the age-groups 40–49, 50–59, 60–69, 70–79, and ≥80 year, in 2020.

Scope of the Report

  • The Hyperopia report covers a detailed overview explaining its causes, symptoms, and pathophysiology, diagnosis, and treatment patterns.
  • The Hyperopia Report and Model provide an overview of the risk factors and global trends of Hyperopia in the seven major markets (7MM: United States, Germany, France, Italy, Spain, and the United Kingdom, and Japan)
  • The report provides insight about the historical and forecasted patient pool of Hyperopia in seven major markets covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population.
  • The report assesses the disease risk and burden and highlights the unmet needs of Hyperopia.
  • The report provides the segmentation of the Hyperopia epidemiology by total prevalent cases in the 7MM.
  • The report provides the segmentation of the Hyperopia epidemiology by diagnosed prevalent cases in the 7MM.
  • The report provides the segmentation of the Hyperopia epidemiology by gender-specific diagnosed prevalent cases in the 7MM.
  • The report provides the segmentation of the Hyperopia epidemiology by age-specific diagnosed prevalent cases in the 7MM.
  • The report provides the segmentation of the Hyperopia epidemiology by severity-specific diagnosed prevalent cases of Hyperopia in the 7MM.
  • The report provides the segmentation of the Hyperopia epidemiology by treated cases of Hyperopia in the 7MM.

Report Highlights

  • 10-Year Forecast of Hyperopia epidemiology
  • 7MM Coverage
  • Epidemiology Segmentation

KOL-Views

We interview, KOL’s and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the over Hyperopia scenario of the indications.

Key Questions Answered

  • What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Hyperopia?
  • What are the key findings pertaining to the Hyperopia epidemiology across the 7MM and which country will have the highest number of patients during the study period (2021-2034)?
  • What would be the total number of patients of Hyperopia across the 7MM during the study period (2021-2034)?
  • Among the EU5 countries, which country will have the highest number of patients during the study period (2021-2034)?
  • At what CAGR the patient population is expected to grow in the 7MM during the study period (2021-2034)?
  • What are the various recent and upcoming events which are expected to improve the diagnosis of Hyperopia?

Reasons to buy

The Hyperopia Epidemiology report will allow the user to -

  • Develop business strategies by understanding the trends shaping and driving the global Hyperopia market
  • Quantify patient populations in the global Hyperopia market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and gender that present the best opportunities for Hyperopia therapeutics in each of the markets covered
  • Understand the magnitude of Hyperopia population by its severity
  • The Hyperopia epidemiology report and model were written and developed by Masters and PhD level epidemiologists
  • The Hyperopia Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 10-year forecast period using reputable sources

Key Assessments

  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

Tags:

    License Type

    Offer

    Request Sample

    View Pricing

    Customize Reports As Per Your Needs

    Don't see what you're looking for? Get a report tailored to your specific requirements. Customize your report now!

    Have a Question?

    We are happy to assist you.

    Support Person
    DelveInsight
    DelveInsight
    SUBSCRIPTION
    Platform

    Register for free trial today and gain instant access to 7000+ market
    research reports

    Latest Press Release